Well Lead Med Co Ltd (SHG:603309) — Market Cap & Net Worth
Market Cap & Net Worth: Well Lead Med Co Ltd (603309)
Well Lead Med Co Ltd (SHG:603309) has a market capitalization of $583.85 Million (CN¥3.99 Billion) as of May 2, 2026. Listed on the SHG stock exchange, this China-based company holds position #11766 globally and #3600 in its home market, demonstrating a 3.48% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Well Lead Med Co Ltd's stock price CN¥13.67 by its total outstanding shares 291871418 (291.87 Million). Analyse 603309 cash flow conversion to see how efficiently the company converts income to cash.
Well Lead Med Co Ltd Market Cap History: 2015 to 2026
Well Lead Med Co Ltd's market capitalization history from 2015 to 2026. Data shows change from $1.33 Billion to $583.85 Million (-5.67% CAGR).
Well Lead Med Co Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Well Lead Med Co Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.34x
Well Lead Med Co Ltd's market cap is 0.34 times its annual revenue
Latest Price to Earnings (P/E) Ratio
2.33x
Well Lead Med Co Ltd's market cap is 2.33 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $1.33 Billion | $548.87 Million | $91.32 Million | 2.43x | 14.62x |
| 2016 | $765.30 Million | $515.42 Million | $79.25 Million | 1.48x | 9.66x |
| 2017 | $559.80 Million | $629.89 Million | $64.56 Million | 0.89x | 8.67x |
| 2018 | $295.58 Million | $745.83 Million | $65.40 Million | 0.40x | 4.52x |
| 2019 | $453.74 Million | $993.81 Million | $121.14 Million | 0.46x | 3.75x |
| 2020 | $512.38 Million | $1.13 Billion | $153.11 Million | 0.45x | 3.35x |
| 2021 | $657.58 Million | $1.12 Billion | $106.09 Million | 0.59x | 6.20x |
| 2022 | $838.47 Million | $1.36 Billion | $166.57 Million | 0.62x | 5.03x |
| 2023 | $607.76 Million | $1.37 Billion | $192.49 Million | 0.44x | 3.16x |
| 2024 | $511.67 Million | $1.51 Billion | $219.39 Million | 0.34x | 2.33x |
Competitor Companies of 603309 by Market Capitalization
Companies near Well Lead Med Co Ltd in the global market cap rankings as of May 2, 2026.
Key companies related to Well Lead Med Co Ltd by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #136 globally with a market cap of $162.57 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #250 globally with a market cap of $98.12 Billion USD ( €83.93 Billion EUR).
- ESSILORLUXOTTICA 1/2/O.N. (F:ESLC): Ranked #274 globally with a market cap of $93.24 Billion USD ( €79.76 Billion EUR).
- HOYA CORP. ADR/ 1 O.N. (F:HYB0): Ranked #523 globally with a market cap of $50.37 Billion USD ( €43.09 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #136 | Intuitive Surgical Inc | NASDAQ:ISRG | $162.57 Billion | $457.78 |
| #250 | EssilorLuxottica S. A. | PA:EL | $98.12 Billion | €181.25 |
| #274 | ESSILORLUXOTTICA 1/2/O.N. | F:ESLC | $93.24 Billion | €88.50 |
| #523 | HOYA CORP. ADR/ 1 O.N. | F:HYB0 | $50.37 Billion | €150.00 |
Well Lead Med Co Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Well Lead Med Co Ltd's market cap moved from $1.33 Billion to $ 583.85 Million, with a yearly change of -5.67%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥583.85 Million | +0.59% |
| 2025 | CN¥580.43 Million | +13.44% |
| 2024 | CN¥511.67 Million | -15.81% |
| 2023 | CN¥607.76 Million | -27.52% |
| 2022 | CN¥838.47 Million | +27.51% |
| 2021 | CN¥657.58 Million | +28.34% |
| 2020 | CN¥512.38 Million | +12.92% |
| 2019 | CN¥453.74 Million | +53.51% |
| 2018 | CN¥295.58 Million | -47.20% |
| 2017 | CN¥559.80 Million | -26.85% |
| 2016 | CN¥765.30 Million | -42.67% |
| 2015 | CN¥1.33 Billion | -- |
End of Day Market Cap According to Different Sources
On May 2nd, 2026 the market cap of Well Lead Med Co Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $583.85 Million USD |
| MoneyControl | $583.85 Million USD |
| MarketWatch | $583.85 Million USD |
| marketcap.company | $583.85 Million USD |
| Reuters | $583.85 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Well Lead Med Co Ltd
Well Lead Medical Co., Ltd. engages in the development, production, and sale of medical devices in urology, endourology, anaesthesia, respiratory, hemodialysis, and pain management areas worldwide. It provides urology products, including Foley catheter, Nelaton catheters, urine collection products, and accessories; endourology products, such as the ClearPetra family system, ureterorenoscope, guid… Read more